Life science investors and corporate finance

Urgent reimbursement analysis within 2 weeks to support Med Tech and In-Vitro Diagnostics acquisition decisions

What is included in our reimbursement due diligence report?

Openness of EU markets to technology

Current uptake of technology

Current reimbursement levels

Restrictions in technology use by health authorities (indications, size of population)

Pathways, timelines and requirements to establish sufficient reimbursement

Contact us to request example of the reimbursement report

Our services cover 14 European countries, including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-interventional procedures

Medical aids

In-vitro diagnostic tests

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring and insulin injection, use of fusidial markers, radiotherapy, endoscopy and more

Check out our database of off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • Transcatheter aortic valve implantation (TAVI) 
  • Eight minimally invasive and transcatheter mitral valve repair and replacement technologies
  • Group of peripheral vascular arterial interventions (angioplasty, angioplasty using drug-eluting balloon, stenting using bare metal and drug-eluting stents, atherectomy, periperal IVUS)
  • Robotic surgery interventions
  • Peripheral venous interventions for deep vein thrombosis and venous insufficiency
  • Coronary percutaneous revascularization (angioplasty using plain and drug-coated balloon, bare metal and drug-eluting stents, mechanical thrombectomy, percutaneous atherectomy)
  • Coronary percutaneous imaging procedures (angiography, IVUS, FFR, OCT)
  • Mechanical thrombectomy for stroke
  • Ablation of heart tissue for atrial fibrillation
  • Radiotherapy procedures (all types)
  • Surgical and endovascular treatment of brain aneurysm
  • Ventricular assist devices (VADs) for cardiac failure
  • Extra-corporeal membrane oxygenation (ECMO) for cardiac and respiratory failure

Ongoing reports:

  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Hospital and out-patient remote monitoring for neurostimulators
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney and bone
  • Deep brain stimulation
  • Spinal cord stimulation
  • Vagus nerve stimulation
  • Bariatric surgery
  • Hernia repair
  • Vascular access for long-term use: AV fistula and AV graft

Confidence in results

We  have established  numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team, comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Get analysis results within 2 weeks

  • Our standard turnaround time for reimbursement due diligence projects is only 2 weeks
  • During the project you have 24/7 access to the project manager so as to get all the necessary support

Are you interested in learning more about how we can help you?